Cargando…

GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment

BACKGROUND: Mutations in GJB2 are the most common molecular defects responsible for autosomal recessive nonsyndromic hearing impairment (NSHI). The mutation spectra of this gene vary among different ethnic groups. METHODS: In order to understand the spectrum and frequency of GJB2 mutations in the Ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Pu, Yu, Fei, Han, Bing, Liu, Xuezhong, Wang, Guojian, Li, Qi, Yuan, Yongyi, Liu, Xin, Huang, Deliang, Kang, Dongyang, Zhang, Xin, Yuan, Huijun, Yao, Kun, Hao, Jinsheng, He, Jia, He, Yong, Wang, Youqin, Ye, Qing, Yu, Youjun, Lin, Hongyan, Liu, Lijia, Deng, Wei, Zhu, Xiuhui, You, Yiwen, Cui, Jinghong, Hou, Nongsheng, Xu, Xuehai, Zhang, Jin, Tang, Liang, Song, Rendong, Lin, Yongjun, Sun, Shuanzhu, Zhang, Ruining, Wu, Hao, Ma, Yuebing, Zhu, Shanxiang, Wu, Bai-lin, Han, Dongyi, Wong, Lee-Jun C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2679712/
https://www.ncbi.nlm.nih.gov/pubmed/19366456
http://dx.doi.org/10.1186/1479-5876-7-26
_version_ 1782166911440650240
author Dai, Pu
Yu, Fei
Han, Bing
Liu, Xuezhong
Wang, Guojian
Li, Qi
Yuan, Yongyi
Liu, Xin
Huang, Deliang
Kang, Dongyang
Zhang, Xin
Yuan, Huijun
Yao, Kun
Hao, Jinsheng
He, Jia
He, Yong
Wang, Youqin
Ye, Qing
Yu, Youjun
Lin, Hongyan
Liu, Lijia
Deng, Wei
Zhu, Xiuhui
You, Yiwen
Cui, Jinghong
Hou, Nongsheng
Xu, Xuehai
Zhang, Jin
Tang, Liang
Song, Rendong
Lin, Yongjun
Sun, Shuanzhu
Zhang, Ruining
Wu, Hao
Ma, Yuebing
Zhu, Shanxiang
Wu, Bai-lin
Han, Dongyi
Wong, Lee-Jun C
author_facet Dai, Pu
Yu, Fei
Han, Bing
Liu, Xuezhong
Wang, Guojian
Li, Qi
Yuan, Yongyi
Liu, Xin
Huang, Deliang
Kang, Dongyang
Zhang, Xin
Yuan, Huijun
Yao, Kun
Hao, Jinsheng
He, Jia
He, Yong
Wang, Youqin
Ye, Qing
Yu, Youjun
Lin, Hongyan
Liu, Lijia
Deng, Wei
Zhu, Xiuhui
You, Yiwen
Cui, Jinghong
Hou, Nongsheng
Xu, Xuehai
Zhang, Jin
Tang, Liang
Song, Rendong
Lin, Yongjun
Sun, Shuanzhu
Zhang, Ruining
Wu, Hao
Ma, Yuebing
Zhu, Shanxiang
Wu, Bai-lin
Han, Dongyi
Wong, Lee-Jun C
author_sort Dai, Pu
collection PubMed
description BACKGROUND: Mutations in GJB2 are the most common molecular defects responsible for autosomal recessive nonsyndromic hearing impairment (NSHI). The mutation spectra of this gene vary among different ethnic groups. METHODS: In order to understand the spectrum and frequency of GJB2 mutations in the Chinese population, the coding region of the GJB2 gene from 2063 unrelated patients with NSHI was PCR amplified and sequenced. RESULTS: A total of 23 pathogenic mutations were identified. Among them, five (p.W3X, c.99delT, c.155_c.158delTCTG, c.512_c.513insAACG, and p.Y152X) are novel. Three hundred and seven patients carry two confirmed pathogenic mutations, including 178 homozygotes and 129 compound heterozygotes. One hundred twenty five patients carry only one mutant allele. Thus, GJB2 mutations account for 17.9% of the mutant alleles in 2063 NSHI patients. Overall, 92.6% (684/739) of the pathogenic mutations are frame-shift truncation or nonsense mutations. The four prevalent mutations; c.235delC, c.299_c.300delAT, c.176_c.191del16, and c.35delG, account for 88.0% of all mutantalleles identified. The frequency of GJB2 mutations (alleles) varies from 4% to 30.4% among different regions of China. It also varies among different sub-ethnic groups. CONCLUSION: In some regions of China, testing of the three most common mutations can identify at least one GJB2 mutant allele in all patients. In other regions such as Tibet, the three most common mutations account for only 16% the GJB2 mutant alleles. Thus, in this region, sequencing of GJB2 would be recommended. In addition, the etiology of more than 80% of the mutant alleles for NSHI in China remains to be identified. Analysis of other NSHI related genes will be necessary.
format Text
id pubmed-2679712
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26797122009-05-09 GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment Dai, Pu Yu, Fei Han, Bing Liu, Xuezhong Wang, Guojian Li, Qi Yuan, Yongyi Liu, Xin Huang, Deliang Kang, Dongyang Zhang, Xin Yuan, Huijun Yao, Kun Hao, Jinsheng He, Jia He, Yong Wang, Youqin Ye, Qing Yu, Youjun Lin, Hongyan Liu, Lijia Deng, Wei Zhu, Xiuhui You, Yiwen Cui, Jinghong Hou, Nongsheng Xu, Xuehai Zhang, Jin Tang, Liang Song, Rendong Lin, Yongjun Sun, Shuanzhu Zhang, Ruining Wu, Hao Ma, Yuebing Zhu, Shanxiang Wu, Bai-lin Han, Dongyi Wong, Lee-Jun C J Transl Med Research BACKGROUND: Mutations in GJB2 are the most common molecular defects responsible for autosomal recessive nonsyndromic hearing impairment (NSHI). The mutation spectra of this gene vary among different ethnic groups. METHODS: In order to understand the spectrum and frequency of GJB2 mutations in the Chinese population, the coding region of the GJB2 gene from 2063 unrelated patients with NSHI was PCR amplified and sequenced. RESULTS: A total of 23 pathogenic mutations were identified. Among them, five (p.W3X, c.99delT, c.155_c.158delTCTG, c.512_c.513insAACG, and p.Y152X) are novel. Three hundred and seven patients carry two confirmed pathogenic mutations, including 178 homozygotes and 129 compound heterozygotes. One hundred twenty five patients carry only one mutant allele. Thus, GJB2 mutations account for 17.9% of the mutant alleles in 2063 NSHI patients. Overall, 92.6% (684/739) of the pathogenic mutations are frame-shift truncation or nonsense mutations. The four prevalent mutations; c.235delC, c.299_c.300delAT, c.176_c.191del16, and c.35delG, account for 88.0% of all mutantalleles identified. The frequency of GJB2 mutations (alleles) varies from 4% to 30.4% among different regions of China. It also varies among different sub-ethnic groups. CONCLUSION: In some regions of China, testing of the three most common mutations can identify at least one GJB2 mutant allele in all patients. In other regions such as Tibet, the three most common mutations account for only 16% the GJB2 mutant alleles. Thus, in this region, sequencing of GJB2 would be recommended. In addition, the etiology of more than 80% of the mutant alleles for NSHI in China remains to be identified. Analysis of other NSHI related genes will be necessary. BioMed Central 2009-04-14 /pmc/articles/PMC2679712/ /pubmed/19366456 http://dx.doi.org/10.1186/1479-5876-7-26 Text en Copyright © 2009 Dai et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Dai, Pu
Yu, Fei
Han, Bing
Liu, Xuezhong
Wang, Guojian
Li, Qi
Yuan, Yongyi
Liu, Xin
Huang, Deliang
Kang, Dongyang
Zhang, Xin
Yuan, Huijun
Yao, Kun
Hao, Jinsheng
He, Jia
He, Yong
Wang, Youqin
Ye, Qing
Yu, Youjun
Lin, Hongyan
Liu, Lijia
Deng, Wei
Zhu, Xiuhui
You, Yiwen
Cui, Jinghong
Hou, Nongsheng
Xu, Xuehai
Zhang, Jin
Tang, Liang
Song, Rendong
Lin, Yongjun
Sun, Shuanzhu
Zhang, Ruining
Wu, Hao
Ma, Yuebing
Zhu, Shanxiang
Wu, Bai-lin
Han, Dongyi
Wong, Lee-Jun C
GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment
title GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment
title_full GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment
title_fullStr GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment
title_full_unstemmed GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment
title_short GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment
title_sort gjb2 mutation spectrum in 2063 chinese patients with nonsyndromic hearing impairment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2679712/
https://www.ncbi.nlm.nih.gov/pubmed/19366456
http://dx.doi.org/10.1186/1479-5876-7-26
work_keys_str_mv AT daipu gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT yufei gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT hanbing gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT liuxuezhong gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT wangguojian gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT liqi gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT yuanyongyi gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT liuxin gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT huangdeliang gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT kangdongyang gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT zhangxin gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT yuanhuijun gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT yaokun gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT haojinsheng gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT hejia gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT heyong gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT wangyouqin gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT yeqing gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT yuyoujun gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT linhongyan gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT liulijia gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT dengwei gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT zhuxiuhui gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT youyiwen gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT cuijinghong gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT hounongsheng gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT xuxuehai gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT zhangjin gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT tangliang gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT songrendong gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT linyongjun gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT sunshuanzhu gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT zhangruining gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT wuhao gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT mayuebing gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT zhushanxiang gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT wubailin gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT handongyi gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment
AT wongleejunc gjb2mutationspectrumin2063chinesepatientswithnonsyndromichearingimpairment